Page 32 - Ischemic Stroke News Today

Increased circulating levels of interleukin 6 are linked to increased carotid plaque severity and progression, say researchers who also identified a way to select patients for anti-IL-6 therapy.

Young stroke patients have an increased risk of being diagnosed with a new cancer in the years following their stroke, a new study shows.

The TWIST trial aimed to show benefit of the new bolus thrombolytic in patients with wake-up stroke selected by noncontrast CT, but turned out to be underpowered to achieve a definitive result.

RACECAT trial results suggest the longer travel times to the comprehensive stroke center -- rather than going to a closer primary stroke center -- could be harmful for patients having a hemorrhagic stroke.

May 10, 2022—Magneto Thrombectomy Solutions, an Israel-based medical device company developing thrombectomy solutions for the treatment of ische

The findings dont end debate on whether an early or standard approach to tracheostomy yields better outcomes, but does give clinicians a choice.

Patients with a higher relative brain age relative to their chronological age had far worse outcomes after stroke, highlighting a biomarker that could be used to guide post-stroke care.

Two studies presented at ESOC strengthen the argument that gut microbiota might play a key role in stroke severity and improving outcomes.

The benefit of endovascular therapy in the treatment of stroke caused by an occlusion of the basilar artery has finally been confirmed in the ATTENTION randomized controlled trial.

The authors suggest that wider use of influenza vaccination could be an effective way to reduce the burden of stroke.